I am a breastfeeding mother and i want to know if it is safe to use UNII-334895S862? Is UNII-334895S862 safe for nursing mother and child? Does UNII-334895S862 extracts into breast milk? Does UNII-334895S862 has any long term or short term side effects on infants? Can UNII-334895S862 influence milk supply or can UNII-334895S862 decrease milk supply in lactating mothers?
- DrLact safety Score for UNII-334895S862 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of UNII-334895S862 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that UNII-334895S862 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of UNII-334895S862 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using UNII-334895S862 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Excreted into breast milk in quantities that would be clinically significant, however, intestinal absorption by infant's gut is hampered because of formation of chelating products by union with the milk's calcium. Tetracycline is at lesser amount excreted into breast milk and at higher proportion bound to calcium, hence, it is fewer absorbed than UNII-334895S862. Thus, it is a optimal alternative while breastfeeding. Long-term treatments are not recommended (over 3-4 weeks) since it may cause damage of the growth cartilage, teeth discoloration and imbalance of intestinal flora. Be aware of false negative results that may be obtained from infants with bacterial cultures when the mother is on antibiotics.
A number of reviews have stated that tetracyclines are contraindicated during breastfeeding because of possible staining of infants' dental enamel or bone deposition of tetracyclines. However, a close examination of available literature indicates that there is not likely to be harm in short-term use of UNII-334895S862 during lactation because milk levels are low and absorption by the infant is inhibited by the calcium in breastmilk. Short-term use of UNII-334895S862 is acceptable in nursing mothers. As a theoretical precaution, avoid prolonged or repeat courses during nursing. Monitor the infant for rash and for possible effects on the gastrointestinal flora, such as diarrhea or candidiasis (thrush, diaper rash).
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.